NOCIL working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
104.65×104.65×115.31×113.68×126.98×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
84.00×84.00×85.23×86.68×89.84×
64.37×64.37×54.04×54.93×70.39×
124.28×124.28×146.50×145.43×146.43×
2.22×1.95×1.80×1.78×2.28×
0.63×0.63×0.68×0.75×0.88×
4.53×4.53×0.25×1.51×1.89×
2.50×2.50×0.19×1.03×1.12×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NOCIL₹145.35

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹2,428 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)126.98113.68115.31104.65104.65
Receivable Days (DSO)89.8486.6885.2384.0084.00
Payable Days (DPO)70.3954.9354.0464.3764.37
Cash Conversion Cycle (days)146.43145.43146.50124.28124.28
Working Capital Turnover2.281.781.801.952.22
Asset Turnover0.880.750.680.630.63
Cash Conversion (CFO/Net Income)1.891.510.254.534.53
CFO/EBITDA1.121.030.192.502.50
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.